Skip to main content
. 2020 Apr 11;30(9):3354–3362. doi: 10.1007/s11695-020-04539-8

Table 8.

Efficacy subgroup analysis

BMI* % TBWL mean (SD)
< 30 (n = 302) 13.3 ± 4.7
30–40 (n = 1230) 14.4 ± 4.9
> 40 (n = 196) 14.7 ± 4.2

*BMI data not available for 42 patients